Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014

European Statistical Forum 2014

17 Nov 2014 - 17 Nov 2014 - Brussels, Belgium

Bookmark and Share

The EUROPEAN STATISTICAL FORUM is pleased to announce its 5th Annual Conference:

The current status of the application of Bayesian Methods in Drug Development

In the last years the biostatistics community has increased its interest in the application of Bayesian methodology in drug development as it provides a framework for determining probabilities relevant to inferences from current trials and previous knowledge.

Bayesian statistics has the potential to play an important role throughout the drug/device development process lifecycle and in particular in the decision-making process. Its range of applications contains early phase studies, dose-finding, safety analyses, meta-analyses, decision theory as well as the quantification of the benefits and risks essential to health economic evaluation. While the use of Bayesian methodologies has significantly increased in the recent years in exploratory clinical trials, its use in confirmatory clinical trials is still not common.

The fifth edition of the European Statistical Forum is dedicated to Bayesian Statistics, in particular by presenting:

  •  Current state-of-art implementation in clinical trials
  •  Recent enhancements in the methodology
  •  Regulatory perspectives on its application in clinical trials.

The conference aims at promoting the exchange of expertise in the field coming from academia and industry as well as regulators.

The Scientific Board:

  • Jens-Otto Andreas, Director, Head Global Biostatistics EU Group, UCB BIOSCIENCES GmbH
  • Lisa Comarella, Director, Biostatistics, Senior Project Manager, Cros NT Group
  • Frank Fleischer, Global BCA, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Giacomo Mordenti, Senior Director Compound Development & Branding-Head Biostatistics, Grünenthal 

will share best practices, results and experiences in this field.

Who should attend?

The conference is addressed to Statisticians and Professionals with a deep interest in the application of Bayesian methodology in clinical trials belonging to: Pharmaceutical, Biotechnology and related Industries, CROs, Academy, Hospital Centres, University.

Pre-Conference Dinner at Aux Armes de Bruxelles, Brussels

Sunday, 16th November, 7:30 pm

For further information, please visit:

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos